Why the study?
Does Left Atrial Appendage occlusion prevent stroke in patients with nonrheumatic atrial fibrillation?
Does Left Atrial Appendage occlusion prevent stroke in patients with nonrheumatic atrial fibrillation?
LAA occlusion represents a viable alternative for stroke prevention in nonrheumatic atrial fibrillation patients who are contraindicated for anticoagulation, though comparative data with novel oral anticoagulants are needed.
Answers are grounded in this paper and cite their sources.
May support LAA occlusion in anticoagulation-contraindicated AF; leaves open randomized comparisons versus NOACs.
LAA-occlusion is a developing field of interventional and surgical techniques. The concept of LAA-occlusion could be proved in one randomized trial. At least for patients contraindicated for anticoagulation therapy, LAA-occlusion is a real alternative to only aspirin therapy or doing nothing. With emerging techniques and lower complication rates, LAA-occlusion might develop to a real alternative to anticoagulation therapy, at least for vitamin-K-antagonists. There are no data available so far in comparison with new oral anticoagulants. Further studies are needed to compare device therapy with new oral anticoagulants.
No takes yet. Share an insight, caveat, or question.
Peter Sick (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: